Postmenopausal women with ER-positive, AR-positive (ER+/AR+) tumours showed significantly better OS than postmenopausal women with ER-positive, AR-negative (ER+/AR-) tumours (p = 0.030) (Fig. 2). This evidence concerns the gene AR and neoplasm.